Top of the morning to you. And a fine one, it is. The birds are chirping, the official Pharmalot mascots are fertilizing the weeds and the short people are on their way to the local schoolhouses. 'Tis cause for celebration and, as you know, there is only one way we do so at this hour - a delicious cup of stimulation. Free free to join us. Now, though, we need to busy ourselves. We know you can relate, so here are a few items to get you going. Have a great day and keep us in mind if you spot something interesting...
AstraZeneca Sues FDA Over Rejection Of Generic Seroquel Petition (Reuters)
Pfizer Scraps Insulin Deal with India's Biocon (Reuters)
FDA Panel Supports More Research For Nerve-Blocking Pain Drugs (Associated Press)
J&J May Face $1.8B Risperdal Settlement Demand (Bloomberg News)
Dendreon CEO Believes Rival Prostate Drugs Will Boost Market (Reuters)
Brigham Young Professor And Pfizer Head To Trial Over Celebrex (Deseret News)
UK's NICE Wants More Info On J&J & Bayer's Xalreto (Pharma Times)
Scotland Rejects J&J Zytiga Prostate Drug As Too Costly (BBC News)
Pfizer Says Study Backs Prevnar For Use In Older Kids (Bloomberg News)
Can Statins Prevent Parkinson's Disease? (HealthDay)
CRO Caught In Dateline Sting Says Report Was Distorted (Outsourcing Pharma)
Pediatric Safety Targeted By EMA In Excipient Update (InPharma Technologist)
EDITOR'S NOTE: Please check this post for updates throughout the morning
1 Comment
Susie Q will hit the streets on March 26, on schedule.